Loading...

Randall, Leslie Michelle

TitleAssociate Clinical Professor
InstitutionUniversity of California, Irvine
DepartmentObstetrics and Gynecology
Address1001 Health Sciences Road
CA 92697-3950
Phone(714) 456-6026
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Lim MC, Randall L. Role and clinical application of next-generation sequencing (NGS) for ovarian cancer. J Gynecol Oncol. 2017 07; 28(4):e51. PMID: 28541638.
      View in: PubMed
    2. Randall L, Pothuri B, Swisher EM, Diaz JP, Buchanan A, Witkop CT, Bethan Powell C, Smith EB, Robson ME, Boyd J, Coleman RL, Lu K. Multi-disciplinary summit on genetics services for women with gynecologic cancers: A Society of Gynecologic Oncology White Paper. Gynecol Oncol. 2017 08; 146(2):217-224. PMID: 28596016.
      View in: PubMed
    3. Randall L, Pothuri B. The genetic prediction of risk for gynecologic cancers. Gynecol Oncol. 2016 Apr; 141(1):10-6. PMID: 27016223.
      View in: PubMed
    4. Westin SN, Randall L. The European Society of Gynecologic Oncology (ESGO) 19th biannual meeting: Overview and summary of selected topics. Gynecol Oncol. 2016 Mar; 140(3):377-80. PMID: 26807487.
      View in: PubMed
    5. Eskander RN, Ali S, Dellinger T, Lankes HA, Randall L, Ramirez NC, Monk BJ, Walker JL, Eisenhauer E, Hoang BH. Expression Patterns of the Wnt Pathway Inhibitors Dickkopf3 and Secreted Frizzled-Related Proteins 1 and 4 in Endometrial Endometrioid Adenocarcinoma: An NRG Oncology/Gynecologic Oncology Group Study. Int J Gynecol Cancer. 2016 Jan; 26(1):125-32. PMID: 26397159.
      View in: PubMed
    6. Hodeib M, Chang J, Liu F, Ziogas A, Dilley S, Randall L, Anton-Culver H, Bristow RE. Socioeconomic status as a predictor of adherence to treatment guidelines for early-stage ovarian cancer. Gynecol Oncol. 2015 Jul; 138(1):121-7. PMID: 25913132.
      View in: PubMed
    7. Randall L, Gibson SJ, Monk BJ. The American Society of Clinical Oncology 50th Annual Meeting 2014: an overview and summary of selected abstracts. Gynecol Oncol. 2014 Aug; 134(2):222-7. PMID: 25090931.
      View in: PubMed
    8. Krill LS, Adelson JW, Randall L, Bristow RE. Clinical commentary: Medical ethics and the ramifications of equipoise in clinical research. Is a confirmatory trial using a non-bevacizumab containing arm feasible in patients with recurrent cervical cancer? Gynecol Oncol. 2014 Sep; 134(3):447-9. PMID: 24976631.
      View in: PubMed
    9. Bristow RE, Chang J, Ziogas A, Randall L, Anton-Culver H. High-volume ovarian cancer care: survival impact and disparities in access for advanced-stage disease. Gynecol Oncol. 2014 Feb; 132(2):403-10. PMID: 24361578.
      View in: PubMed
    10. Eskander RN, Ji T, Huynh B, Wardeh R, Randall L, Hoang B. Inhibition of enhancer of zeste homolog 2 (EZH2) expression is associated with decreased tumor cell proliferation, migration, and invasion in endometrial cancer cell lines. Int J Gynecol Cancer. 2013 Jul; 23(6):997-1005. PMID: 23792601; PMCID: PMC3694282.
    11. Moniaga NC, Randall L. Uterine leiomyomatosis with intracaval and intracardiac extension. Gynecol Oncol Case Rep. 2012; 2(4):130-2. PMID: 24371644; PMCID: PMC3861007.
    12. Eskander RN, Randall L, Sakai T, Guo Y, Hoang B, Zi X. Flavokawain B, a novel, naturally occurring chalcone, exhibits robust apoptotic effects and induces G2/M arrest of a uterine leiomyosarcoma cell line. J Obstet Gynaecol Res. 2012 Aug; 38(8):1086-94. PMID: 22540374; PMCID: PMC3405181.
    13. Randall L, Sill MW, Burger RA, Monk BJ, Buening B, Sorosky JI. Predictive value of serum CA-125 levels in patients with persistent or recurrent epithelial ovarian cancer or peritoneal cancer treated with bevacizumab on a Gynecologic Oncology Group phase II trial. Gynecol Oncol. 2012 Mar; 124(3):563-8. PMID: 22138229; PMCID: PMC3278517.
    14. Jordan S, Randall L, Karamurzin Y, Ward P, Lin F, Brewster W, Monk BJ. Differentiating squamous cell carcinoma of the cervix and epithelioid trophoblastic tumor. Int J Gynecol Cancer. 2011 Jul; 21(5):918-22. PMID: 21697681.
      View in: PubMed
    15. Eskander RN, Randall L, Berman ML, Tewari KS, Disaia PJ, Bristow RE. Fertility preserving options in patients with gynecologic malignancies. Am J Obstet Gynecol. 2011 Aug; 205(2):103-10. PMID: 21411052.
      View in: PubMed
    16. Eskander RN, Randall L. Bevacizumab in the treatment of ovarian cancer. Biologics. 2011; 5:1-5. PMID: 21383911; PMCID: PMC3044789.
    17. Han ES, Burger RA, Darcy KM, Sill MW, Randall L, Chase D, Parmakhtiar B, Monk BJ, Greer BE, Connelly P, Degeest K, Fruehauf JP. Predictive and prognostic angiogenic markers in a gynecologic oncology group phase II trial of bevacizumab in recurrent and persistent ovarian or peritoneal cancer. Gynecol Oncol. 2010 Dec; 119(3):484-90. PMID: 20870280; PMCID: PMC2975758.
    18. Moniaga NC, Randall L. Malignant mixed ovarian germ cell tumor with embryonal component. J Pediatr Adolesc Gynecol. 2011 Feb; 24(1):e1-3. PMID: 20869284.
      View in: PubMed
    19. Randall L, Monk BJ, Moon J, Parker R, Al-Ghazi M, Wilczynski S, Fruehauf JP, Markman M, Burger RA. Prospective evaluation of an in vitro radiation resistance assay in locally advanced cancer of the uterine cervix: a Southwest Oncology Group Study. Gynecol Oncol. 2010 Dec; 119(3):417-21. PMID: 20846714.
      View in: PubMed
    20. Randall L, Monk BJ. Bevacizumab toxicities and their management in ovarian cancer. Gynecol Oncol. 2010 Jun; 117(3):497-504. PMID: 20363017.
      View in: PubMed
    21. Liao SY, Darcy KM, Randall L, Tian C, Monk BJ, Burger RA, Fruehauf JP, Peters WA, Stock RJ, Stanbridge EJ. Prognostic relevance of carbonic anhydrase-IX in high-risk, early-stage cervical cancer: a Gynecologic Oncology Group study. Gynecol Oncol. 2010 Mar; 116(3):452-8. PMID: 19913895; PMCID: PMC2822024.
    22. Randall L, Monk BJ, Darcy KM, Tian C, Burger RA, Liao SY, Peters WA, Stock RJ, Fruehauf JP. Markers of angiogenesis in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group study. Gynecol Oncol. 2009 Mar; 112(3):583-9. PMID: 19110305; PMCID: PMC2858218.
    23. Randall-Whitis LM, Monk BJ. Topotecan in the management of cervical cancer. Expert Opin Pharmacother. 2007 Feb; 8(2):227-36. PMID: 17257092.
      View in: PubMed